Latest Innovation News

Lithium Universe has achieved a major milestone with its JESE technology, recovering silver at near-commercial purity while enhancing material performance and sustainability. This innovation could reshape silver recycling and premium electronics supply chains.

Epiminder Limited has settled a $15.77 million tax liability with the ATO related to historical R&D claims, freeing up $4.23 million from IPO proceeds for working capital.

Elsight Limited has landed a substantial US$21.2 million contract for early 2026 deliveries, marking a dramatic increase in forward orders and reinforcing its role in the global defence and uncrewed systems sector.

Metal Powder Works has formalized a partnership with Austal USA to develop custom metal powders for US Navy additive manufacturing, positioning MPW within a critical defense supply chain.

Lincoln Minerals has entered a collaboration with SCN Canada to explore the use of its high-purity graphite in small modular nuclear reactors, aiming to tap into emerging clean energy markets.

PointsBet Holdings Limited has appointed Andrew Catterall as Group CEO effective February 2026, with founder Sam Swanell transitioning to an advisory role while remaining on the Board.

Nanoveu’s subsidiary EMASS has completed the design phase of its cutting-edge 16nm ECS-DoT Edge AI system-on-chip, moving closer to fabrication and silicon validation that could redefine ultra-low-power AI at the edge.

Brazilian Critical Minerals Ltd has produced a high-grade mixed rare earth carbonate with 52.5% total rare earth oxides and 41.5% magnet rare earth oxides from its Ema Project field trials, validating a low-capital in-situ recovery process.

Harmoney Corp Limited reported a staggering 742% increase in Cash NPAT for FY25, driven by its new Stellare® 2.0 platform and operational efficiencies. The company reaffirmed its ambitious $12 million profit target for FY26 while unveiling a secured car loan product and securing a major bank debt facility.

Locate Technologies has completed its redomiciliation from Australia to New Zealand, establishing Locate NZ as the new parent company and appointing MUFG Pension & Market Services as its share registry provider.

Recce Pharmaceuticals has won a significant Australian Government R&D tax incentive, unlocking up to A$85 million for its synthetic anti-infective programs worldwide, including a pivotal Phase 3 clinical trial.

Emyria has secured its first Empax clinic in Victoria, marking a significant step in its multi-state expansion and validating its scalable, reimbursed national mental health platform.